by Denise Purdie Andrews | May 12, 2025 | Announcements, Drug Classes
At this year’s MATT meeting, Dr. Laureen Marinetti spoke to attendees about how to differentiate between ketamine used illicitly versus ketamine used medically. She also discussed the origin of medical and illicit ketamine. Ketamine was developed in 1962 for use as...
by Denise Purdie Andrews | Apr 24, 2025 | Announcements
At this year’s MATT meeting, Stuart Kurtz spoke to attendees about the prevalence of nitazene analogs and the concentrations at which Axis detects them. We have previously discussed what nitazenes are in blog posts (see links below). As a reminder, they are potent mu...
by Denise Purdie Andrews | Mar 26, 2025 | Announcements
Axis toxicologists Laureen Marinetti, PhD, F-ABFT, and Stuart Kurtz, M.S, D-ABFT-FT, will be presenting at the Midwest Association of Toxicology and Therapeutic Drug Monitoring (MATT) Annual Meeting in Milwaukee Wisconsin, April 2-4, 2025. Their presentation topics...
by Denise Purdie Andrews | Mar 11, 2025 | Drug Classes
By Kevin Shanks, D-ABFT-FT 1,1-Difluoroethane (DFE) is a chemical compound that belongs to the family of hydrofluorocarbons, also known as HFCs. DFE has a chemical formula C2H4F2 and is a colorless, odorless gas at room temperature and is commonly used as a...
by Denise Purdie Andrews | Mar 3, 2025 | Announcements
We are excited to share some great news with you! Based on your valuable feedback and our ongoing efforts to improve our products, we are pleased to announce the addition of 1,1-Difluoroethane to our Comprehensive Panel with Analyte Assurance™, effective 3/10/2025....
